Name Development Level Target Family
Name Description
ruxolitinib a kinase inhibitor, inhibits Janus Associated Kinases (JAKs) JAK1 and JAK2 which mediate the signaling of a number of cytokines and growth factors that are important for hematopoiesis and immune function
TCRDv4.6.9
DrugCentral Indication
DrugCentral
ruxolitinib